WO2014196068A1 - Drug information management device, drug information management system, and drug information management method - Google Patents

Drug information management device, drug information management system, and drug information management method Download PDF

Info

Publication number
WO2014196068A1
WO2014196068A1 PCT/JP2013/065736 JP2013065736W WO2014196068A1 WO 2014196068 A1 WO2014196068 A1 WO 2014196068A1 JP 2013065736 W JP2013065736 W JP 2013065736W WO 2014196068 A1 WO2014196068 A1 WO 2014196068A1
Authority
WO
WIPO (PCT)
Prior art keywords
information
drug
side effect
medicine
registered
Prior art date
Application number
PCT/JP2013/065736
Other languages
French (fr)
Japanese (ja)
Inventor
昭二 岩本
智則 望月
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to PCT/JP2013/065736 priority Critical patent/WO2014196068A1/en
Publication of WO2014196068A1 publication Critical patent/WO2014196068A1/en

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Definitions

  • the present invention relates to a drug information management device, a drug information management system, and a drug information management method, for example, which are held by an individual who takes a drug or the like and manages information such as the drug to be taken.
  • Such a “medicine notebook” is configured by filling medicine information in a paper notebook or pasting a prescription, etc., and as such, there is a problem that it is difficult to handle bulky information.
  • a “medicine notebook using electronic paper” or the like that is stored and stored is proposed (for example, Patent Document 1).
  • the present invention provides a drug information management device, a drug information management system, and a drug information management method that can easily and reliably report side effect information and the like related to a drug of the patient to medical personnel such as a doctor. With the goal.
  • the above object is a drug information management device comprising various information input units that can input various types of information from outside and various information output units that output various types of information, Stores drug information including drug identification information, which is information for specifying a prescribed drug, and drug side effect occurrence information, which is information on occurrence of side effects, as the already registered drug information, and then the various information input unit
  • drug information including drug identification information, which is information for specifying a prescribed drug
  • drug side effect occurrence information which is information on occurrence of side effects
  • the drug information management device has already stored drug information including drug identification information such as a drug name that is information for specifying a prescribed drug and drug side effect occurrence information that is information on occurrence of the side effect. It is stored as registered drug information. After that, when the drug specifying information input from various information input units matches the drug specifying information of the already registered drug information, whether or not the already registered drug information is associated with the drug side effect occurrence information. Are associated with each other, the fact that the drug specifying information is accompanied by drug side effect occurrence information is output to various information output units.
  • drug identification information such as a drug name that is information for specifying a prescribed drug
  • drug side effect occurrence information that is information on occurrence of the side effect. It is stored as registered drug information.
  • the side-effect determination standard information of a specific drug acquires pre-dose biometric information that is patient biometric information before taking the specific drug, and includes patient biometric information after taking the specific drug. It also obtains certain biometric information after taking, determines the presence or absence of side effects related to the specific drug based on the change information of both and the side effect determination criteria information, and when it is determined that a side effect has occurred, the side effect of the drug A feature is that the generation information is generated.
  • the above configuration it is configured to determine whether or not a side effect related to the specific drug has occurred, and to generate drug side effect occurrence information when it is determined that a side effect has occurred. For this reason, even when the patient takes the first medicine, if a side effect occurs by taking the medicine, the fact can be automatically judged and stored. Therefore, the fact that a side effect has occurred can be automatically stored in relation to the drug without the patient or the like operating the drug management device and inputting the information “drug side effect”, so that it is easy to use. It becomes a management device.
  • the side effect determination criterion information is generated based on a specific wording regarding a side effect indicated in the precaution information regarding the drug specifying information input from the various information input units. .
  • the drug information management apparatus can automatically grasp the side effect that occurs for the drug, for example, information such as fever. Therefore, even if the patient refers to the package insert, etc., operates the drug information management device, and does not input the information on the “side effect (fever etc.)” that occurs, the content of the side effect is automatically related to the drug. Therefore, the medicine information management device is easy to use.
  • the potency of the same type of drug is higher than that of the already registered drug information.
  • it is configured to output that the medicinal effect is reduced to the various information output units.
  • medical agent specific information is the same kind drugs, such as a generic drug different from the chemical
  • a medicine information management system comprising: the medicine information management apparatus; and a medical institution side medicine management apparatus arranged to be communicable with the medicine information management apparatus, wherein the medicine information is associated with patient identification information.
  • the identification information and the drug information are transmitted from the drug information management device to the medical institution side drug management device and recorded in an electronic medical record arranged in the medical institution side drug management device.
  • the medicine information stored in the medicine information management apparatus can be automatically stored in the electronic medical record of the medical institution side medicine management apparatus, the medical institution stores the medicine information stored in the medicine information management apparatus.
  • the process of inputting to the medical institution side medicine management apparatus can be omitted. Therefore, the system is easy to use for medical institutions.
  • the drug identification information including the drug identification information for identifying the prescribed drug and the drug side effect occurrence information as the occurrence information of the side effect are registered in the present invention.
  • the drug specifying information input from various information input units that can input various information from the outside coincides with the drug specifying information of the registered drug information. It is determined whether or not the already registered drug information is associated with the drug side effect occurrence information.
  • various information indicating that the drug specifying information is accompanied with the drug side effect occurrence information is displayed. This is achieved by a medicine information management method characterized in that the information is output to various information output units.
  • a drug information management device As described above, according to the present invention, a drug information management device, a drug information management system, and drug information that can easily and reliably report side effect information and the like related to a drug of the patient to medical personnel such as a doctor.
  • a management method can be provided.
  • FIG. 1 is a schematic diagram showing, for example, a medicine notebook management system 1 which is a medicine information management system of the present invention.
  • the medicine notebook management system 1 has, for example, an activity meter 10 which is a medicine information management device.
  • the activity meter 10 has, for example, a three-axis acceleration sensor and the like, and is a device that measures vital data such as intensity of activity and biological information such as total daily calories consumed such as sleep, walk, work, housework, etc. is there.
  • the activity meter 10 since the activity meter 10 is always carried by a user such as a patient due to its nature, not only the total calorie consumption is measured, but also the “drug name” and It has a function of storing drug information such as “side effect information”.
  • “activity meter 10” is shown as a drug information management device that stores drug information and the like.
  • the drug information management device of the present invention is not limited to the activity meter 10, and such information is available. Any medium can be used as long as it can be stored, is convenient for carrying, and has a GUI (Graphical User Interface) function.
  • it may be a portable terminal such as a cellular phone, a data card, a clock, a key, or the like.
  • the activity meter 10 carried by the patient has a thermometer 3, a sphygmomanometer 4, and a blood glucose meter 5 that are always provided in the patient home 2 when the patient is in the patient home 2.
  • the short-range wireless communication is possible on the condition that they are arranged within a certain distance.
  • the activity meter 10 is configured to acquire biometric data such as body temperature, blood pressure value, blood glucose level, and the like from the thermometer 3, blood pressure meter 4 and blood glucose meter 5 by wireless communication.
  • Examples of short-range wireless communication include non-contact communication means for short distances up to about 10 cm (for example, power-saving IC communication technology of ISO / IEC 14443, communication technology of ISO / IEC 18092, FeliCa (Sony Corporation) (Registered trademark)), Bluetooth (registered trademark of Bluetooth SIG), and the like.
  • FeliCa communication technology communication is performed using radio waves of 13.56 MHz, and communication of 100 to 400 kbps is performed in a very close range up to about 10 cm.
  • Bluetooth can communicate at a maximum speed of 24 Mbps using radio waves in the 2.45 GHz band.
  • the activity meter 10 has, for example, activity meter side input devices 11a, 11b, and 11c which are various information input units.
  • the activity meter side input devices 11a, 11b, and 11c are button-like protrusions, switches for inputting signals when pressed, and the like, which are operated by a patient or the like.
  • the activity meter 10 also includes, for example, an activity meter-side communication device 12 that is various information input units capable of short-range wireless communication with an external device or the like.
  • the activity meter 10 includes, for example, an activity meter-side display 13 that is various information output units, and is configured to display various information described later.
  • the medical institution side drug management device For example, the communication with the hospital server 60 is possible. Specifically, as shown in FIG. 1, short-range wireless communication is performed via a “hospital server side read / write device 61” connected to the hospital server 60.
  • the activity meter 10 is connected via the “pharmacy server side read / write device 71”. It has a configuration capable of distance wireless communication.
  • the activity meter 10, the hospital server 60, the pharmacy server 70, the thermometer 3, the sphygmomanometer 4, the blood glucose meter 5 and the like shown in FIG. 1 have computers, and the computer includes a CPU (Central Processing Unit), a RAM (not shown), and a RAM. (Random Access Memory), ROM (Read Only Memory), etc., which are connected via a bus.
  • a CPU Central Processing Unit
  • RAM Random Access Memory
  • ROM Read Only Memory
  • FIG. 2 is a schematic block diagram showing the main configuration of the hospital server 60 of FIG.
  • the hospital server 60 has a hospital server control unit 62.
  • the hospital server control unit 62 stores a hospital server side communication device 63 for communicating with the hospital server side read / write device 61, various data.
  • a hospital server side display 64 to be displayed and a hospital server side input device 65 for inputting various data are controlled.
  • the hospital server control unit 62 also controls a “medicine information storage unit 66”, an “electronic medical record information storage unit 67”, and the like shown in FIG.
  • FIG. 3 is a schematic block diagram showing the main configuration of the activity meter 10 of FIG.
  • the activity meter 10 includes an activity meter control unit 14, and the activity meter control unit 14 includes the activity meter side communication device 12, the activity meter side display 13, and the activity amount.
  • the meter side input devices 11a, 11b11c and the like are controlled.
  • the activity meter control unit 14 also controls the “first various information storage unit 20” and the “second various information storage unit 30” shown in FIG.
  • FIGS. 4 and 5 are schematic block diagrams showing main configurations of the “first various information storage unit 20” and the “second various information storage unit 30” in FIG. 3, respectively. Specific contents thereof will be described later.
  • FIGS. 1 to 5 are schematic flowcharts showing main steps of the medicine notebook management system 1.
  • a patient who is a user of this system always carries the activity meter 10 of FIG. 1 in order to measure his / her activity.
  • the activity meter 10 exhibits the function of the conventional “medicine notebook”, it is always carried when the patient visits the hospital 6 or the pharmacy 7.
  • step ST (hereinafter referred to as “ST”) 1 in FIG.
  • a doctor in charge prescribes a drug to a patient at the hospital 6, and the prescription information is stored in the “drug information storage unit 66” of FIG. 2 together with “patient ID number” that is identification information of the patient.
  • the hospital server 60 is based on the information in the “electronic medical record information storage unit 67”, for example, “pharmaceutical name information” and “attached document information (an example of precautionary note information)” that are drug specifying information of a prescribed drug. Is extracted from the “drug information storage unit 66” and transmitted to the activity meter 10.
  • this transmission is executed via the “hospital server side read / write device 61” in FIG.
  • the “side effect information” eg, fever, blood pressure increase, blood pressure decrease, etc.
  • This “side effect information” is an example of side effect judgment criterion information.
  • the process proceeds to ST2.
  • the “activity meter 10” stores the received “drug information” in the “drug information storage unit 21” of FIG. 4 as “drug information 21a”. That is, the received “attached document” and “side effect information (fever etc.)” are stored in association with the drug name A or the like.
  • the process proceeds to ST3.
  • the “first side effect detection unit (program) 22” in FIG. 4 operates, refers to the “attached document” in the “drug information 21a” in FIG. ”Or“ blood pressure increase ”or the like (an example of specific wording), and after that, it is determined whether or not there is a keyword such as“ possible ”or“ recognized ”.
  • the process then proceeds to ST6.
  • the “second side effect detection unit (program) 23” of FIG. 4 operates, refers to “attached document” of “drug information 21a” of FIG. 4, and includes the wording of “side effect” in the title of “attached document”. It is determined whether there is a keyword such as “fever” or “blood pressure lowering” as side effects in the paragraph below the title.
  • ST6 If a corresponding keyword exists in ST6, the process proceeds to ST7.
  • the corresponding “fever”, “blood pressure reduction”, etc. are stored as “side effect information” in “drug information 21a” in FIG.
  • “side effect information (fever etc.)” stored in “drug information 21a” in FIG. 4 is displayed on the activity meter side display 13 in FIG.
  • side effect information is input in ST3, the process proceeds to ST9.
  • the inputted “side effect information (fever etc.)” is stored in “drug information 21a” of FIG. 4 and the stored “side effect information” is displayed on the activity meter side display 13.
  • the activity meter 10 obtains “side effect information” from the attached document or the like. Since it is automatically extracted, the activity meter 10 is easy to use for patients and the like.
  • the active mass meter 10 determines from the “thermometer 3”, “blood pressure meter 4”, “blood glucose meter 5”, etc. in FIG. 1 to “body temperature information”, “blood pressure information”, “blood glucose level information”, etc. before taking the drug. Is stored in the “pre-medicinal vital information storage unit 24” of FIG. “Pre-drug vital information” such as body temperature information stored in the “pre-medical vital information storage unit 24” is an example of pre-dose biometric information.
  • the process proceeds to ST11.
  • the active mass meter 10 displays on the “active mass meter side display 13” a screen “whether or not a medicine has been taken” and “input name of medicine taken”.
  • the process proceeds to ST12.
  • it is determined whether or not an input of a drug name and a signal indicating that the drug has been taken have been input.
  • the process proceeds to ST13.
  • the active mass meter 10 uses the “medical name information”, “thermometer 3”, “blood pressure meter 4”, “blood glucose meter 5”, etc. taken from the “medical temperature information”, “blood pressure information” and “ The “blood glucose level information” is acquired and stored in the “post-medical vital information storage unit 25” in FIG. 4 as “post-medical vital information”.
  • This post-drug vital information is an example of post-dose biometric information.
  • the process proceeds to ST14.
  • the “side effect occurrence determination unit (program) 26” of FIG. 4 operates, and “pre-medicine vital information” and “post-medical vital information storage unit 25” of the “pre-medicine vital information storage unit 24”. Are compared with each other, and it is determined whether or not the difference is recognized as a side effect of the drug based on the “side effect threshold information” in the “side effect threshold information storage unit 31” in FIG.
  • the side effect threshold information includes specific threshold information in which “body temperature”, “blood pressure increase”, “blood pressure decrease” and the like are recognized as side effects.
  • the process proceeds to ST15.
  • the process proceeds to ST16.
  • the activity meter 10 stores the drug as “provisional side effect drug” in “drug information 21a” of the “drug information storage unit 21” in FIG. I have a higher body temperature. It may have caused side effects.
  • This “provisional side effect drug” information is an example of drug side effect occurrence information.
  • the activity meter 10 automatically determines that a side effect may have occurred in the medicine taken by the patient carrying the activity meter 10 and stores the fact. .
  • the device since it is not necessary for the patient to input the occurrence of a side effect, the device is easy to use.
  • the process proceeds to ST17.
  • the occurrence of a side effect is a tentative provisional determination, and therefore, in ST17 and subsequent steps, a process for seeking a determination by a doctor in charge is requested.
  • the doctor in charge or the like determines the data determined by the activity meter 10 as “provisional side effect drug” and similarly determines that it is “side effect”, and waits for the “confirmation signal” from the hospital server 60. It is a process. Specifically, this is a case where the patient carries his / her active mass meter 10, goes to the hospital for medical examination, and shows the “side effect” data to the doctor in charge. When the doctor in charge who sees this data determines that it is a side effect, a “confirmation signal” is input directly or via the hospital server 60.
  • a “confirmation signal”, that is, a “confirmed side effect drug” signal is input in ST17, the process proceeds to ST18.
  • the drug in the “drug information storage unit 21” is stored as a “confirmed side effect drug”. Therefore, this confirms that the drug is a “side effect drug” that caused side effects for the patient.
  • the occurrence of a side effect is temporarily estimated and notified to a patient or the like, but since the decision information is awaited by a specialist doctor or the like, the decision information is highly reliable information. It has become.
  • the “determined side effect drug” is also an example of drug side effect occurrence information.
  • the process proceeds to ST19.
  • the “activity meter 10” transmits the “confirmed side effect information” of the drug information 21a to the hospital server 60, and the hospital server 60 stores it in the “electronic medical record information storage unit 67” of FIG. Therefore, the latest side effect information of the patient is automatically reflected in the “electronic medical record” of the hospital, and the doctor in charge or the like can always make an accurate judgment when selecting the medicine.
  • the process proceeds to ST20.
  • ST20 it is determined whether or not there is a cancellation signal of “provisional side effect drug” in the drug information 21a from the hospital server 60 or a doctor in charge directly. If there is a cancel signal, the process proceeds to ST21.
  • ST21 since no side effect has occurred in the drug, the information of “provisional side effect drug” of the drug in the drug information storage unit 21 is deleted. In this way, in this embodiment, information that is not supported by the doctor in charge is quickly deleted, and it is possible to prevent misunderstandings and the like from occurring in patients and the like.
  • FIG. 9 is a schematic flowchart showing an operation example when a patient carries his / her own activity meter 10 and receives a medical examination by a doctor who does not regularly visit, that is, when he / she visits a travel destination. is there.
  • a patient or the like who sees a doctor or the like shows his / her activity meter 10 to the doctor or the like.
  • doctors and the like operate the activity meter 10 shown in FIG. 1 and input a request for viewing “drug information 21a” in order to know what drugs the patient takes and side effects. To do.
  • ST31 when there is an input of a request for viewing “medicine information 21a”, the process proceeds to ST32.
  • the “ordinary side effect drug” or “determined side effect drug” is stored in the “medicine information 21a” of FIG. Is displayed on the activity meter side display 13 as a “side effect drug”. Further, “medicine” that is not “provisional side effect drug” or “confirmed side effect drug” is displayed as “ordinary drug”.
  • FIGS. 12 and 13 are schematic diagrams illustrating an operation example and a display example of the activity meter 10.
  • the doctor or the like can use, for example, the switch 11c of the activity meter side input device 11c. Press.
  • FIG. 12A a list of drug names classified into the above-mentioned “ordinary drugs” in the “drug information 21a” is displayed on the activity meter side display 13.
  • the activity meter side input devices 11a and 11b of FIG. 12A are operated, the screen scrolls up and down, and all “normal medicines” can be easily visually recognized.
  • doctors and the like can obtain necessary information, for example, names of side effect drugs and details of side effects, quickly and accurately by a simple operation.
  • ST33 “medicine information” related to the prescription is transmitted to the activity meter 10 from the hospital-side read / write device 61 of the hospital server 60 of the hospital 6 where the patient is consulting.
  • drug information or the like is transmitted from the pharmacy read / write device 71 of the pharmacy server 70 of the pharmacy 7 to the activity meter 10.
  • the process proceeds to ST34.
  • the “activity meter 10” stores the received “drug information” in the “drug information storage unit 21” of FIG.
  • the process proceeds to ST35.
  • the “side effect drug corresponding determination unit (program) 33” in FIG. 5 operates, and it is determined whether or not the input “drug name” matches “side effect drug” in “drug information 21a” in FIG. to decide.
  • the process proceeds to ST42.
  • the “activity meter 10” stores the received “drug information” in the “drug information storage unit 21” of FIG.
  • the process proceeds to ST43.
  • ST43 it is determined whether or not the input “drug name” is a new drug name, that is, the same as the drug name stored in “drug information 21a” in FIG.
  • the process proceeds to ST44.
  • ST44 it is determined whether or not the new drug name is a generic drug of the same type as the drug name registered in the “medicine information 21a” of FIG. If it is determined in ST44 that the drug is a generic drug, the process proceeds to ST45.
  • the activity meter 10 acquires “body temperature information”, “blood pressure information”, and “blood glucose level information” before taking the drug from the “thermometer”, “blood pressure meter”, “blood glucose meter”, etc. Stored in the “pre-medicine vital information storage unit 24”.
  • Step 46 “whether or not a new medicine has been taken” and “input of the name of a new medicine taken” screen are displayed on the “activity meter side display 13”.
  • ST47 it is determined whether or not a signal indicating that a new medicine has been taken has been input. If it has been input, the process proceeds to ST48.
  • the active mass meter 10 uses the “medicine name information”, “thermometer”, “blood pressure meter”, “blood glucose meter”, etc. taken from the “medical temperature information”, “blood pressure information” and “blood glucose level information” after taking the drug. Is acquired and stored in the “post-medical vital information storage unit 25” in FIG.
  • ST49 the “medicine efficacy comparison / determination unit (program) 34” of FIG. 5 operates, and the “pre-medicine vital information storage unit 24” and the “pre-medicinal vital information storage unit 24” Compare the “post-drug vital information”, obtain the difference, and refer to the “regular drug efficacy information storage unit 35” in FIG. 5 to determine whether the drug efficacy is inferior to that of the same type of drug. to decide.
  • the “regular drug efficacy information storage unit 35” stores past drug efficacy information of a drug corresponding to the same type of drug stored as “drug information”. For example, in the case of an antihypertensive agent, information about a decrease in blood pressure is stored. Therefore, “regular drug efficacy information” is an example of drug efficacy information of already registered drug information.
  • ST50 If it is determined in ST50 that the generic drug is inferior to the existing “normal drug”, the process proceeds to ST51.
  • ST 51 “Warning: Drug efficacy has been reduced by changing the normal medicine” is displayed on the activity meter side display 13.
  • SYMBOLS 1 Medicine notebook management system, 2 ... Patient home, 3 ... Thermometer, 4 ... Blood pressure meter, 5 ... Blood glucose meter, 6 ... Hospital, 7 ... Pharmacy, 10 ... Activity meter, 11a, 11b, 11c ... Activity meter side input device, 12 ... Activity meter side communication device, 13 ... Activity meter side display, 14 ... Activity meter Control part, 20 ... 1st various information storage part, 21 ... Drug information storage part, 21a ... Drug information, 22 ... 1st side effect detection part (program), 23 ... 2nd side effect Discovery unit (program), 24 ... pre-drug vital information storage unit, 25 ... post-drug vital information storage unit, 26 ...
  • side effect occurrence determination unit program
  • 30 second type Information storage unit
  • 31 Side effect threshold information storage unit
  • 32 (Program)
  • 33 ... side effect medicine corresponding judgment part (program)
  • 34 ... medicinal efficacy comparison judgment part (program)
  • 35 ... regular medicine medicinal information storage part, 60 ... hospital server, 61 ... Hospital server side read / write device, 70 ... pharmacy server, 71 ... pharmacy server side read / write device

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

[Problem] To provide a drug information management device, etc., whereby it is possible to easily and reliably notify medical practitioners, etc., such as doctors, of side effect information, etc., relating to a drug of a patient. [Solution] Provided is a drug information management device (10), comprising input units for various information (11a, 11b, 11c) which are capable of receiving input of various information from an external source, and an output unit for various information (13) which outputs various information. Drug information (21a) is stored as pre-registered drug information, including at least drug specification information which is information for specifying a prescribed drug and drug side effect occurrence information which is information of an occurrence of a side effect thereof. When drug specification information which is inputted thereafter via the input units for various information matches the drug specification information of the pre-registered drug information, a determination is made as to whether the pre-registered drug information is linked with the drug side effect occurrence information, and if so linked, the information that the drug specification information has the drug side effect occurrence information associated therewith is outputted to the output unit for various information.

Description

薬剤情報管理装置、薬剤情報管理システム及び薬剤情報管理方法Drug information management device, drug information management system, and drug information management method
　本発明は、例えば、薬剤等を服用する個人等が所持等し、服用する薬剤等の情報を管理する薬剤情報管理装置、薬剤情報管理システム及び薬剤情報管理方法に関するものである。 The present invention relates to a drug information management device, a drug information management system, and a drug information management method, for example, which are held by an individual who takes a drug or the like and manages information such as the drug to be taken.
　従来より、薬剤等を服用する患者等は、自己が服用等している薬剤等の情報を記載した手帳である「お薬手帳」を所持している。この「お薬手帳」には、当該患者が服用している薬剤等の情報や、副作用が生じた薬剤等の情報も記載されている。
　したがって、患者が病院等に診断を受けに行くとき、この「お薬手帳」を所持し、担当医師等に示すことで、医師等は当該患者の薬剤情報を迅速に把握することができ、例えば、副作用が生じる薬剤を処方等することを未然に防ぐことができる。 2. Description of the Related Art Conventionally, patients who take medicines or the like have a “medicine notebook” which is a notebook in which information on the medicines they are taking is recorded. This “medicine notebook” also includes information on drugs taken by the patient and information on drugs with side effects.
Therefore, when a patient goes to a hospital or the like for diagnosis, he / she possesses this “medicine notebook” and shows it to the doctor in charge, etc., so that the doctor etc. can quickly grasp the drug information of the patient, It is possible to prevent prescribing drugs that cause side effects.
　このような「お薬手帳」は、紙製の手帳に、薬剤情報を記入し，又は処方箋等を貼り付けて構成されるため、使用するにつれて、かさばり取り扱い難いという問題があるため、情報を電子化して記憶させる「電子ペーパーを用いたお薬手帳」等が提案されている（例えば、特許文献１）。 Such a “medicine notebook” is configured by filling medicine information in a paper notebook or pasting a prescription, etc., and as such, there is a problem that it is difficult to handle bulky information. A “medicine notebook using electronic paper” or the like that is stored and stored is proposed (for example, Patent Document 1).
特開２０１１―３４３２５号公報JP 2011-34325 A
　しかしながら、電子化された「お薬手帳」であっても、その記憶されているデータが多くなると、どの薬剤で副作用が生じたか否か等の情報を把握し難いという問題があった。 However, even with an electronic “medicine notebook”, when the stored data increases, there is a problem that it is difficult to grasp information such as which drug has a side effect.
　そこで、本発明は、当該患者の薬剤に関する副作用情報等を簡易且つ確実に医師等の医療従事者等に報知することができる薬剤情報管理装置、薬剤情報管理システム及び薬剤情報管理方法を提供することを目的とする。 Therefore, the present invention provides a drug information management device, a drug information management system, and a drug information management method that can easily and reliably report side effect information and the like related to a drug of the patient to medical personnel such as a doctor. With the goal.
　上記目的は、本発明にあっては、外部から各種情報を入力することができる各種情報入力部と、各種情報を出力する各種情報出力部と、を備える薬剤情報管理装置であって、少なくとも、処方された薬剤を特定するための情報である薬剤特定情報及びその副作用の発生情報である薬剤副作用発生情報を含む薬剤情報を既登録の前記薬剤情報として記憶すると共に、その後、前記各種情報入力部から入力された前記薬剤特定情報が、前記既登録の前記薬剤情報の前記薬剤特定情報と一致するときに、当該既登録の前記薬剤情報が前記薬剤副作用発生情報と関連付けられているか否かを判断し、関連付けられているときは、当該薬剤特定情報が前記薬剤副作用発生情報を伴っていることを前記各種情報出力部に出力する構成となっていることを特徴とする薬剤情報管理装置により達成される。 In the present invention, the above object is a drug information management device comprising various information input units that can input various types of information from outside and various information output units that output various types of information, Stores drug information including drug identification information, which is information for specifying a prescribed drug, and drug side effect occurrence information, which is information on occurrence of side effects, as the already registered drug information, and then the various information input unit When the medicine specifying information inputted from the medicine matches the medicine specifying information of the registered medicine information, it is determined whether or not the registered medicine information is associated with the medicine side effect occurrence information. And when it is associated, the fact that the drug specifying information is accompanied by the drug side effect occurrence information is output to the various information output units. It is achieved by the drug information management apparatus according to symptoms.
　前記構成によれば、薬剤情報管理装置には、処方された薬剤を特定するための情報である薬剤名等の薬剤特定情報及びその副作用の発生情報である薬剤副作用発生情報を含む薬剤情報が既登録の薬剤情報として記憶されている。
　そして、その後、各種情報入力部から入力された薬剤特定情報が、既登録の薬剤情報の薬剤特定情報と一致するときに、当該既登録の薬剤情報が薬剤副作用発生情報と関連付けられているか否かを判断し、関連付けられているときは、当該薬剤特定情報が薬剤副作用発生情報を伴っていることを各種情報出力部に出力する構成となっている。
　したがって、患者等が、その服用した薬剤等とその副作用情報を、自己の当該薬剤情報管理装置に蓄積し、その結果、情報量が多くなった場合であっても、その後、医師等の医療従事者が処方した薬剤の情報を当該薬剤情報管理装置の各種入力部に入力するだけで、当該薬剤について、過去、当該患者が副作用を発生させたことがあるか否かを簡易且つ確実に知ることができる。 According to the above configuration, the drug information management device has already stored drug information including drug identification information such as a drug name that is information for specifying a prescribed drug and drug side effect occurrence information that is information on occurrence of the side effect. It is stored as registered drug information.
After that, when the drug specifying information input from various information input units matches the drug specifying information of the already registered drug information, whether or not the already registered drug information is associated with the drug side effect occurrence information. Are associated with each other, the fact that the drug specifying information is accompanied by drug side effect occurrence information is output to various information output units.
Therefore, even if a patient or the like accumulates the medicine taken and its side effect information in the drug information management apparatus of the patient, and as a result, the amount of information increases, the medical professional such as a doctor or the like thereafter By simply inputting information about the medicine prescribed by the person into the various input sections of the medicine information management apparatus, it is possible to easily and surely know whether or not the patient has caused side effects in the past. Can do.
　好ましくは、特定の薬剤の副作用判断基準情報を有し、特定の薬剤の服用前における患者の生体情報である服用前生体情報を取得すると共に、当該特定の薬剤の服用後における患者の生体情報である服用後生体情報も取得し、両者の変化情報及び前記副作用判断基準情報に基づき、当該特定の薬剤に関する副作用の発生の有無を判断し、副作用が発生したと判断されたときは、前記薬剤副作用発生情報を生成する構成となっていることを特徴とする。 Preferably, it has side-effect determination standard information of a specific drug, acquires pre-dose biometric information that is patient biometric information before taking the specific drug, and includes patient biometric information after taking the specific drug. It also obtains certain biometric information after taking, determines the presence or absence of side effects related to the specific drug based on the change information of both and the side effect determination criteria information, and when it is determined that a side effect has occurred, the side effect of the drug A feature is that the generation information is generated.
　前記構成によれば、当該特定の薬剤に関する副作用の発生の有無を判断し、副作用が発生したと判断されたときは、薬剤副作用発生情報を生成する構成となっている。
　このため、患者が初めての薬剤を服用するときでも、その服用により副作用が発生するときは、自動的にその事実を判断し、記憶させることができる。
　したがって、患者等が薬剤管理装置を操作して「薬剤副作用発生」の情報を入力することなく、自動的に副作用発生の事実を薬剤との関連で記憶されることができるので、使い易い薬剤情報管理装置となる。 According to the above configuration, it is configured to determine whether or not a side effect related to the specific drug has occurred, and to generate drug side effect occurrence information when it is determined that a side effect has occurred.
For this reason, even when the patient takes the first medicine, if a side effect occurs by taking the medicine, the fact can be automatically judged and stored.
Therefore, the fact that a side effect has occurred can be automatically stored in relation to the drug without the patient or the like operating the drug management device and inputting the information “drug side effect”, so that it is easy to use. It becomes a management device.
　好ましくは、前記各種情報入力部から入力された前記薬剤特定情報に関する注意書情報に示された副作用に関する特定文言に基づいて、前記副作用判断基準情報を生成する構成となっていることを特徴とする。 Preferably, the side effect determination criterion information is generated based on a specific wording regarding a side effect indicated in the precaution information regarding the drug specifying information input from the various information input units. .
　前記構成によれば、薬剤特定情報に関する添付文書等の注意書情報に示された副作用に関する発熱等のキーワード等の特定文言に基づいて、副作用判断基準情報を生成する構成となっている。
　このため、当該薬剤について、発生する副作用、例えば、発熱等の情報を当該薬剤情報管理装置は自動的に把握することができる。
　したがって、患者等が添付文書等を参照し、薬剤情報管理装置を操作して、発生する「副作用（発熱等）」の情報を入力しなくても、自動的に副作用の内容を薬剤との関連で記憶されることができるので、使い易い薬剤情報管理装置となる。 According to the said structure, it becomes the structure which produces | generates side effect judgment reference | standard information based on specific words, such as a keyword, such as a fever regarding the side effect shown in cautionary notes information, such as an attached document regarding medicine specific information.
For this reason, the drug information management apparatus can automatically grasp the side effect that occurs for the drug, for example, information such as fever.
Therefore, even if the patient refers to the package insert, etc., operates the drug information management device, and does not input the information on the “side effect (fever etc.)” that occurs, the content of the side effect is automatically related to the drug. Therefore, the medicine information management device is easy to use.
　好ましくは、入力された前記薬剤特定情報が、既登録の前記薬剤情報の前記薬剤特定情報と異なる同種薬剤であるときは、既登録の前記薬剤情報の薬効情報と比べ、前記同種薬剤の薬効が低下したと判断されたときは、薬効が低下していることを前記各種情報出力部に出力する構成となっていることを特徴とする。 Preferably, when the inputted drug specifying information is the same kind of drug different from the drug specifying information of the registered drug information, the potency of the same type of drug is higher than that of the already registered drug information. When it is determined that it has been reduced, it is configured to output that the medicinal effect is reduced to the various information output units.
　前記構成によれば、入力された薬剤特定情報が、既登録の前記薬剤情報の薬剤特定情報と異なるジェネリック等の同種薬剤であるときは、既登録の前記薬剤情報の薬効情報と比べる。そして、同種薬剤の薬効が低下したと判断されたときは、薬効が低下していることを各種情報出力部に出力する構成となっている。
　したがって、患者等がジェネリック医薬品等の同種薬剤に変更して服用した場合、その変更によって薬効等が低下したか否かを患者等に報知することができる。 According to the said structure, when the input chemical | medical agent specific information is the same kind drugs, such as a generic drug different from the chemical | medical agent specific information of the said registered drug information, it compares with the medicinal effect information of the said registered drug information. And when it is judged that the medicinal effect of the same kind medicine fell, it has composition which outputs that the medicinal effect falls to various information output parts.
Therefore, when a patient or the like changes to a similar drug such as a generic drug and takes the same, the patient or the like can be notified whether the change has reduced the efficacy or the like.
　好ましくは、前記薬剤情報管理装置と、前記薬剤情報管理装置と通信可能に配置される医療機関側薬剤管理装置と、を有する薬剤情報管理システムであって、前記薬剤情報は患者の識別情報と関連付けて登録されており、この識別情報及び前記薬剤情報が、前記薬剤情報管理装置から前記医療機関側薬剤管理装置に送信され、前記医療機関側薬剤管理装置に配置される電子カルテに記録される構成となっていることを特徴とする薬剤情報管理システム。 Preferably, a medicine information management system comprising: the medicine information management apparatus; and a medical institution side medicine management apparatus arranged to be communicable with the medicine information management apparatus, wherein the medicine information is associated with patient identification information. The identification information and the drug information are transmitted from the drug information management device to the medical institution side drug management device and recorded in an electronic medical record arranged in the medical institution side drug management device. A drug information management system characterized by
　前記構成によれば、薬剤情報管理装置が記憶した薬剤情報を医療機関側薬剤管理装置の電子カルテにも自動的に記憶させることができるので、医療機関が、薬剤情報管理装置が記憶した薬剤情報を自己の医療機関側薬剤管理装置に入力等する工程を省略することができる。したがって、医療機関等にとっても使い易いシステムとなる。 According to the above configuration, since the medicine information stored in the medicine information management apparatus can be automatically stored in the electronic medical record of the medical institution side medicine management apparatus, the medical institution stores the medicine information stored in the medicine information management apparatus. The process of inputting to the medical institution side medicine management apparatus can be omitted. Therefore, the system is easy to use for medical institutions.
　上記目的は、本発明にあっては、少なくとも、処方された薬剤を特定するための情報である薬剤特定情報及びその副作用の発生情報である薬剤副作用発生情報を含む薬剤情報を既登録の前記薬剤情報として記憶すると共に、その後、外部から各種情報を入力することができる各種情入力部から入力された前記薬剤特定情報が、前記既登録の前記薬剤情報の前記薬剤特定情報と一致するときに、当該既登録の前記薬剤情報が前記薬剤副作用発生情報と関連付けられているか否かを判断し、関連付けられているときは、当該薬剤特定情報が前記薬剤副作用発生情報を伴っていることを各種情報を出力する各種情報出力部に出力する構成となっていることを特徴とする薬剤情報管理方法により達成される。 In the present invention, at least the drug identification information including the drug identification information for identifying the prescribed drug and the drug side effect occurrence information as the occurrence information of the side effect are registered in the present invention. When memorizing as information, and then the drug specifying information input from various information input units that can input various information from the outside coincides with the drug specifying information of the registered drug information, It is determined whether or not the already registered drug information is associated with the drug side effect occurrence information. When the registered drug information is associated, various information indicating that the drug specifying information is accompanied with the drug side effect occurrence information is displayed. This is achieved by a medicine information management method characterized in that the information is output to various information output units.
　以上説明したように、本発明によれば、当該患者の薬剤に関する副作用情報等を簡易且つ確実に医師等の医療従事者等に報知することができる薬剤情報管理装置、薬剤情報管理システム及び薬剤情報管理方法を提供することができる。 As described above, according to the present invention, a drug information management device, a drug information management system, and drug information that can easily and reliably report side effect information and the like related to a drug of the patient to medical personnel such as a doctor. A management method can be provided.
本発明の薬剤情報管理システムである例えば、お薬手帳管理システムを示す概略図である。It is the schematic which shows the medicine notebook management system which is the chemical | medical agent information management system of this invention, for example. 図１の病院サーバの主な構成を示す概略ブロック図である。It is a schematic block diagram which shows the main structures of the hospital server of FIG. 図１の活動量計の主な構成を示す概略ブロック図である。It is a schematic block diagram which shows the main structures of the active mass meter of FIG. 図３の第１各種情報記憶部の主な構成を示す概略ブロック図である。It is a schematic block diagram which shows the main structures of the 1st various information storage part of FIG. 図３の第２各種情報記憶部の主な構成を示す概略ブロック図である。It is a schematic block diagram which shows the main structures of the 2nd various information storage part of FIG. お薬手帳管理システムの主な工程を示す概略フローチャートである。It is a schematic flowchart which shows the main processes of a medicine notebook management system. お薬手帳管理システムの主な工程を示す他の概略フローチャートである。It is another schematic flowchart which shows the main processes of a medicine notebook management system. お薬手帳管理システムの主な工程を示す他の概略フローチャートである。It is another schematic flowchart which shows the main processes of a medicine notebook management system. お薬手帳管理システムの主な工程を示す他の概略フローチャートである。It is another schematic flowchart which shows the main processes of a medicine notebook management system. お薬手帳管理システムの主な工程を示す他の概略フローチャートである。It is another schematic flowchart which shows the main processes of a medicine notebook management system. お薬手帳管理システムの主な工程を示す他の概略フローチャートである。It is another schematic flowchart which shows the main processes of a medicine notebook management system. 活動量計の操作例及び表示例を示す概略図である。It is the schematic which shows the operation example and display example of an active mass meter. 活動量計の操作例及び表示例を示す他の概略図である。It is another schematic diagram showing an operation example and a display example of the activity meter.
　以下、この発明の好適な実施の形態を、添付図面等を参照しながら、詳細に説明する。
　尚、以下に述べる実施の形態は、本発明の好適な具体例であるから、技術的に好ましい種々の限定が付されているが、本発明の範囲は、以下の説明において特に本発明を限定する旨の記載がない限り、これらの態様に限られるものではない。 DESCRIPTION OF EMBODIMENTS Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings.
The embodiments described below are preferred specific examples of the present invention, and thus various technically preferable limitations are given. However, the scope of the present invention is particularly limited in the following description. Unless otherwise stated, the present invention is not limited to these embodiments.
　図１は、本発明の薬剤情報管理システムである例えば、お薬手帳管理システム１を示す概略図である。
　図１に示すように、お薬手帳管理システム１は、薬剤情報管理装置である例えば、活動量計１０を有している。
　活動量計１０は、例えば、３軸加速度センサ等を有し、活動の強さと睡眠や散歩、仕事、家事等１日の総消費カロリーなどの生体情報である例えば、バイタルデータを計測する装置である。
　本実施の形態では、活動量計１０は、その性質上、患者等の利用者が常時、携帯しているため、その総消費カロリーの計測だけでなく、患者等が服用する「薬剤名」及び「副作用情報」等の薬剤情報を記憶等する機能を有している。
　なお、本実施の形態では、薬剤情報を記憶等する薬剤情報管理装置として「活動量計１０」を示したが、本発明の薬剤情報管理装置は、活動量計１０に限らず、かかる情報が記憶でき携帯に便利で、ＧＵＩ（Ｇｒａｐｈｉｃａｌ　Ｕｓｅｒ　Ｉｎｔｅｒｆａｃｅ）機能を有する媒体等であればよく、例えば、携帯電話等の携帯端末やデータカード、時計、鍵等であっても構わない。 FIG. 1 is a schematic diagram showing, for example, a medicine notebook management system 1 which is a medicine information management system of the present invention.
As shown in FIG. 1, the medicine notebook management system 1 has, for example, an activity meter 10 which is a medicine information management device.
The activity meter 10 has, for example, a three-axis acceleration sensor and the like, and is a device that measures vital data such as intensity of activity and biological information such as total daily calories consumed such as sleep, walk, work, housework, etc. is there.
In the present embodiment, since the activity meter 10 is always carried by a user such as a patient due to its nature, not only the total calorie consumption is measured, but also the “drug name” and It has a function of storing drug information such as “side effect information”.
In the present embodiment, “activity meter 10” is shown as a drug information management device that stores drug information and the like. However, the drug information management device of the present invention is not limited to the activity meter 10, and such information is available. Any medium can be used as long as it can be stored, is convenient for carrying, and has a GUI (Graphical User Interface) function. For example, it may be a portable terminal such as a cellular phone, a data card, a clock, a key, or the like.
　また、図１に示すように、患者が携帯している活動量計１０は、患者が患者宅２に居るときは、患者宅２内に常備されている体温計３、血圧計４及び血糖計５等と一定の距離内に配置されることを条件に、近距離無線通信が可能な構成となっている。
　このため、活動量計１０は、生体情報である例えば、体温、血圧値、血糖値等のデータを、体温計３，血圧計４及び血糖計５から無線通信で取得する構成となっている。 As shown in FIG. 1, the activity meter 10 carried by the patient has a thermometer 3, a sphygmomanometer 4, and a blood glucose meter 5 that are always provided in the patient home 2 when the patient is in the patient home 2. The short-range wireless communication is possible on the condition that they are arranged within a certain distance.
For this reason, the activity meter 10 is configured to acquire biometric data such as body temperature, blood pressure value, blood glucose level, and the like from the thermometer 3, blood pressure meter 4 and blood glucose meter 5 by wireless communication.
　近距離無線通信の例としては、～１０ｃｍ程度までの近距離の非接触通信手段（例えば、ＩＳＯ／ＩＥＣ　１４４４３の省電力ＩＣ通信技術、ＩＳＯ／ＩＥＣ　１８０９２の通信技術、ＦｅｌｉＣａ（ソニー（株）の登録商標））、Ｂｌｕｅｔｏｏｔｈ（Ｂｌｕｅｔｏｏｔｈ ＳＩＧの登録商標）等の通信技術等も適用できる。
　ＦｅｌｉＣａの通信技術では、１３．５６ＭＨｚの電波で通信し、１０ｃｍ程度までのごく近距離で非接触に１００～４００ｋｂｐｓの通信が行なわれる。Ｂｌｕｅｔｏｏｔｈでは、２．４５ＧＨｚ帯の電波を利用し、最高２４Ｍｂｐｓの速度で通信を行うことができる。 Examples of short-range wireless communication include non-contact communication means for short distances up to about 10 cm (for example, power-saving IC communication technology of ISO / IEC 14443, communication technology of ISO / IEC 18092, FeliCa (Sony Corporation) (Registered trademark)), Bluetooth (registered trademark of Bluetooth SIG), and the like.
In the FeliCa communication technology, communication is performed using radio waves of 13.56 MHz, and communication of 100 to 400 kbps is performed in a very close range up to about 10 cm. Bluetooth can communicate at a maximum speed of 24 Mbps using radio waves in the 2.45 GHz band.
　ところで、図１に示すように、活動量計１０は、各種情報入力部である例えば、活動量計側入力装置１１ａ、１１ｂ、１１ｃを有している。この活動量計側入力装置１１ａ、１１ｂ、１１ｃは、図１に示すように、ボタン状の突出部や押下することで信号が入力されるスイッチ等であって、患者等が、これらを操作することで、活動量１０に各種の情報を入力することができる構成となっている。なお、後述するように、活動量計１０は、外部の機器等と近距離無線通信が可能な各種情報入力部である例えば、活動量計側通信装置１２も有している。
　また、図１に示すように、活動量計１０は、各種情報出力部である例えば、活動量計側ディスプレイ１３を有し、後述する各種情報が表示される構成となっている。 By the way, as shown in FIG. 1, the activity meter 10 has, for example, activity meter side input devices 11a, 11b, and 11c which are various information input units. As shown in FIG. 1, the activity meter side input devices 11a, 11b, and 11c are button-like protrusions, switches for inputting signals when pressed, and the like, which are operated by a patient or the like. Thus, various types of information can be input to the activity amount 10. As will be described later, the activity meter 10 also includes, for example, an activity meter-side communication device 12 that is various information input units capable of short-range wireless communication with an external device or the like.
As shown in FIG. 1, the activity meter 10 includes, for example, an activity meter-side display 13 that is various information output units, and is configured to display various information described later.
　また、図１に示すように、患者等が活動量計１０を携帯して、病院６に診察を受けに行き、その後、薬局７に薬の提供を受けに行くと、医療機関側薬剤管理装置である例えば、病院サーバ６０と通信可能な構成となっている。具体的には、図１に示すように、病院サーバ６０に接続されている「病院サーバ側リードライト装置６１」を介して短距離無線通信が実行される構成となっている。 As shown in FIG. 1, when a patient or the like carries an active mass meter 10, goes to the hospital 6 for medical examination, and then goes to the pharmacy 7 to receive medicine, the medical institution side drug management device For example, the communication with the hospital server 60 is possible. Specifically, as shown in FIG. 1, short-range wireless communication is performed via a “hospital server side read / write device 61” connected to the hospital server 60.
　一方、薬局７も「薬局サーバ７０」を有し、「薬局サーバ側リードライト装置７１」が接続されているので、活動量計１０は、この「薬局サーバ側リードライト装置７１」を介して近距離無線通信が可能な構成となっている。 On the other hand, since the pharmacy 7 also has the “pharmacy server 70” and the “pharmacy server side read / write device 71” is connected, the activity meter 10 is connected via the “pharmacy server side read / write device 71”. It has a configuration capable of distance wireless communication.
　また、図１に示す活動量計１０、病院サーバ６０、薬局サーバ７０、体温計３，血圧計４及び血糖計５等は、コンピュータを有し、コンピュータは、図示しないＣＰＵ（Ｃｅｎｔｒａｌ　Ｐｒｏｃｅｓｓｉｎｇ　Ｕｎｉｔ）、ＲＡＭ（Ｒａｎｄｏｍ　Ａｃｃｅｓｓ　Ｍｅｍｏｒｙ）、ＲＯＭ（Ｒｅａｄ　Ｏｎｌｙ　Ｍｅｍｏｒｙ）等を有し、これらは、バスを介して接続されている。 Further, the activity meter 10, the hospital server 60, the pharmacy server 70, the thermometer 3, the sphygmomanometer 4, the blood glucose meter 5 and the like shown in FIG. 1 have computers, and the computer includes a CPU (Central Processing Unit), a RAM (not shown), and a RAM. (Random Access Memory), ROM (Read Only Memory), etc., which are connected via a bus.
　図２は、図１の病院サーバ６０の主な構成を示す概略ブロック図である。図２に示すように、病院サーバ６０は、病院サーバ制御部６２を有し、病院サーバ制御部６２は、病院サーバ側リードライト装置６１と通信するための病院サーバ側通信装置６３、各種データを表示する病院サーバ側ディスプレイ６４及び各種データを入力する病院サーバ側入力装置６５等を制御している。
　また、病院サーバ制御部６２は、図２に示す「薬剤情報記憶部６６」や「電子カルテ情報記憶部６７」等も制御しているが、これらの具体的な内容は後述する。 FIG. 2 is a schematic block diagram showing the main configuration of the hospital server 60 of FIG. As shown in FIG. 2, the hospital server 60 has a hospital server control unit 62. The hospital server control unit 62 stores a hospital server side communication device 63 for communicating with the hospital server side read / write device 61, various data. A hospital server side display 64 to be displayed and a hospital server side input device 65 for inputting various data are controlled.
The hospital server control unit 62 also controls a “medicine information storage unit 66”, an “electronic medical record information storage unit 67”, and the like shown in FIG.
　図３は、図１の活動量計１０の主な構成を示す概略ブロック図である。図３に示すように、活動量計１０は、活動量計制御部１４を有し、活動量計制御部１４は、上述の活動量計側通信装置１２、活動量計側ディスプレイ１３及び活動量計側入力装置１１ａ、１１ｂ１１ｃ等を制御している。
　また、活動量計制御部１４は、図３に示す「第１各種情報記憶部２０」及び「第２各種情報記憶部３０」も制御している。 FIG. 3 is a schematic block diagram showing the main configuration of the activity meter 10 of FIG. As shown in FIG. 3, the activity meter 10 includes an activity meter control unit 14, and the activity meter control unit 14 includes the activity meter side communication device 12, the activity meter side display 13, and the activity amount. The meter side input devices 11a, 11b11c and the like are controlled.
The activity meter control unit 14 also controls the “first various information storage unit 20” and the “second various information storage unit 30” shown in FIG.
　図４及び図５は、それぞれ図３の「第１各種情報記憶部２０」及び「第２各種情報記憶部３０」の主な構成を示す概略ブロック図である。これらの具体的な内容は後述する。 FIGS. 4 and 5 are schematic block diagrams showing main configurations of the “first various information storage unit 20” and the “second various information storage unit 30” in FIG. 3, respectively. Specific contents thereof will be described later.
　図６乃至図１１は、お薬手帳管理システム１の主な工程を示す概略フローチャートである。以下、これらのフローチャートに沿って説明すると共に、図１乃至図５の構成等についても説明する。
　本実施の形態では、本システムの利用者である患者は、自己の活動量を計測するため、図１の活動量計１０を常に携帯している。
　また、この活動量計１０は、従来の「お薬手帳」の機能を発揮するため、患者が病院６や薬局７を訪れるときは、常に携帯する。 6 to 11 are schematic flowcharts showing main steps of the medicine notebook management system 1. Hereinafter, the description will be made along these flowcharts, and the configuration of FIGS. 1 to 5 will be described.
In the present embodiment, a patient who is a user of this system always carries the activity meter 10 of FIG. 1 in order to measure his / her activity.
In addition, since the activity meter 10 exhibits the function of the conventional “medicine notebook”, it is always carried when the patient visits the hospital 6 or the pharmacy 7.
　そして、図６のステップＳＴ（以下「ＳＴ」とする）１へ進む。ＳＴ１では、病院６で担当医師が患者に対して薬剤を処方し、その処方情報を図２の「薬剤情報記憶部６６」に当該患者の識別情報である「患者ＩＤ番号」等と共に記憶される。
　次いで、病院サーバ６０は「電子カルテ情報記憶部６７」の情報に基づき、処方された薬剤の薬剤特定情報である例えば、「薬剤名情報」及びその「添付文書情報（注意書情報の一例）」を「薬剤情報記憶部６６」から抽出し、活動量計１０に送信する。
　この送信は，具体的には、図１の「病院サーバ側リードライト装置６１」を介して実行される。
　このとき、「添付文書情報」全体を送信するのではなく、当該薬剤の「添付文書」中の「副作用情報（例えば、発熱、血圧上昇、血圧降下等）」を「副作用情報」として明記して送信してもよい。
　この「副作用情報」が副作用判断基準情報の一例となっている。 Then, the process proceeds to step ST (hereinafter referred to as “ST”) 1 in FIG. In ST1, a doctor in charge prescribes a drug to a patient at the hospital 6, and the prescription information is stored in the “drug information storage unit 66” of FIG. 2 together with “patient ID number” that is identification information of the patient. .
Next, the hospital server 60 is based on the information in the “electronic medical record information storage unit 67”, for example, “pharmaceutical name information” and “attached document information (an example of precautionary note information)” that are drug specifying information of a prescribed drug. Is extracted from the “drug information storage unit 66” and transmitted to the activity meter 10.
Specifically, this transmission is executed via the “hospital server side read / write device 61” in FIG.
At this time, instead of sending the entire “package information”, the “side effect information (eg, fever, blood pressure increase, blood pressure decrease, etc.)” in the “package insert” of the drug is clearly specified as “side effect information”. You may send it.
This “side effect information” is an example of side effect judgment criterion information.
　一方、病院６では、処方箋を発行するだけで、活動量計１０への「薬剤情報」の入力が、薬局７で行われる場合は、薬局サーバ７０から薬局サーバ側リードライト装置７１を介して、上述の「薬剤名情報」及びその「添付文書情報」等が活動量計１０に送信されることになる。 On the other hand, in the hospital 6, when the “pharmaceutical information” is input to the activity meter 10 at the pharmacy 7 simply by issuing a prescription, from the pharmacy server 70 via the pharmacy server side read / write device 71, The above-mentioned “medicine name information” and its “attached document information” are transmitted to the activity meter 10.
　次いで、ＳＴ２へ進む。ＳＴ２では、「活動量計１０」は、受信した「薬剤情報」を図４の「薬剤情報記憶部２１」に「薬剤情報２１ａ」として記憶する。
　すなわち、薬剤名Ａ等に関連付けて、受信した「添付文書」や「副作用情報（発熱等）」を記憶する。
　次いで、ＳＴ３へ進む。ＳＴ３では、図４の「薬剤情報２１ａ」に「副作用情報」が記憶されているか否かを判断し、記憶されていない場合は、ＳＴ４へ進む。
　ＳＴ４では、図４の「第１副作用発見部（プログラム）２２」が動作し、図４の「薬剤情報２１ａ」の「添付文書」を参照し、当該添付文書の文言に、副作用である「発熱」や「血圧上昇」等のキーワード（特定文言の一例）があり、その後に「の可能性がある」や「が認められる」等のキーワードがあるか否かを判断する。 Next, the process proceeds to ST2. In ST2, the “activity meter 10” stores the received “drug information” in the “drug information storage unit 21” of FIG. 4 as “drug information 21a”.
That is, the received “attached document” and “side effect information (fever etc.)” are stored in association with the drug name A or the like.
Next, the process proceeds to ST3. In ST3, it is determined whether or not “side effect information” is stored in “drug information 21a” in FIG. 4. If not stored, the process proceeds to ST4.
In ST4, the “first side effect detection unit (program) 22” in FIG. 4 operates, refers to the “attached document” in the “drug information 21a” in FIG. ”Or“ blood pressure increase ”or the like (an example of specific wording), and after that, it is determined whether or not there is a keyword such as“ possible ”or“ recognized ”.
　ＳＴ４で、該当するキーワード等が存在すると判断されたときは、ＳＴ５へ進む。ＳＴ５では、該当するキーワードである「発熱」や「血圧上昇」等を「副作用情報」として、図４の「薬剤情報２１ａ」に記憶する。 When it is determined in ST4 that the corresponding keyword exists, the process proceeds to ST5. In ST5, the corresponding keywords “fever”, “blood pressure increase” and the like are stored as “side effect information” in “drug information 21a” in FIG.
　一方、次いで、ＳＴ６へ進む。ＳＴ６では、図４の「第２副作用発見部（プログラム）２３」が動作し、図４の「薬剤情報２１ａ」の「添付文書」を参照し、「添付文書」のタイトルに「副作用」の文言を含み、そのタイトル以下の段落に、副作用である「発熱」や「血圧低下」等のキーワードがあるか否かを判断する。 On the other hand, the process then proceeds to ST6. In ST6, the “second side effect detection unit (program) 23” of FIG. 4 operates, refers to “attached document” of “drug information 21a” of FIG. 4, and includes the wording of “side effect” in the title of “attached document”. It is determined whether there is a keyword such as “fever” or “blood pressure lowering” as side effects in the paragraph below the title.
　ＳＴ６で、該当するキーワード等が存在したときは、ＳＴ７へ進む。ＳＴ７では、該当する「発熱」や「血圧低下」等を「副作用情報」として，図４の「薬剤情報２１ａ」に記憶する。
　そして、図４の「薬剤情報２１ａ」に記憶されている「副作用情報（発熱等）」を図１の活動量計側ディスプレイ１３に表示する。 If a corresponding keyword exists in ST6, the process proceeds to ST7. In ST7, the corresponding “fever”, “blood pressure reduction”, etc. are stored as “side effect information” in “drug information 21a” in FIG.
Then, “side effect information (fever etc.)” stored in “drug information 21a” in FIG. 4 is displayed on the activity meter side display 13 in FIG.
　一方、ＳＴ６で、該当するキーワード等が存在しないときは、ＳＴ８へ進む。ＳＴ８では、図４の「薬剤情報２１ａ」の「副作用情報」の記憶があるか否かを判断し、存在しない場合は、ＳＴ１へ戻り、「薬剤情報２１ａ」の再入力を促す。もしくは、本工程を終了する。 On the other hand, if there is no corresponding keyword in ST6, the process proceeds to ST8. In ST8, it is determined whether or not “side effect information” of “drug information 21a” in FIG. 4 is stored. If not, the process returns to ST1 and prompts for re-input of “drug information 21a”. Alternatively, this process is terminated.
　また、ＳＴ３で「副作用情報」の入力があったときは、ＳＴ９へ進む。ＳＴ９では、入力された「副作用情報（発熱等）」を図４の「薬剤情報２１ａ」に記憶し、記憶された「副作用情報」を活動量計側ディスプレイ１３に表示する。
　このように、本実施の形態では、処方された薬剤Ａ等の副作用情報（発熱等）を病院サーバ６０等から取得しなかったときでも、活動量計１０が添付文書等から「副作用情報」を自動的に抽出するので、患者等にとって使い易い活動量計１０となる。 If “side effect information” is input in ST3, the process proceeds to ST9. In ST9, the inputted “side effect information (fever etc.)” is stored in “drug information 21a” of FIG. 4 and the stored “side effect information” is displayed on the activity meter side display 13.
As described above, in the present embodiment, even when the side effect information (fever etc.) of the prescribed medicine A or the like is not acquired from the hospital server 60 or the like, the activity meter 10 obtains “side effect information” from the attached document or the like. Since it is automatically extracted, the activity meter 10 is easy to use for patients and the like.
　次いで、ＳＴ１０へ進む。ＳＴ１０では、活動量計１０が、図１の「体温計３」、「血圧計４」及び「血糖計５」等から薬剤服用前の「体温情報」、「血圧情報」及び「血糖値情報」等を取得し、図４の「薬剤服用前バイタル情報記憶部２４」に記憶する。
　この「薬剤服用前バイタル情報記憶部２４」に記憶される体温情報等の「薬剤服用前バイタル情報」が服用前生体情報の一例となっている。 Next, the process proceeds to ST10. In ST10, the active mass meter 10 determines from the “thermometer 3”, “blood pressure meter 4”, “blood glucose meter 5”, etc. in FIG. 1 to “body temperature information”, “blood pressure information”, “blood glucose level information”, etc. before taking the drug. Is stored in the “pre-medicinal vital information storage unit 24” of FIG.
“Pre-drug vital information” such as body temperature information stored in the “pre-medical vital information storage unit 24” is an example of pre-dose biometric information.
　次いで、ＳＴ１１へ進む。ＳＴ１１では、活動量計１０が、「活動量計側ディスプレイ１３」に「薬剤を服用したか否か」及び「服用した薬剤名の入力」画面が表示される。
　次いで、ＳＴ１２へ進む。ＳＴ１２では、薬剤名の入力と当該薬剤の服用済みの信号が入力されたか否かが判断される。 Next, the process proceeds to ST11. In ST11, the active mass meter 10 displays on the “active mass meter side display 13” a screen “whether or not a medicine has been taken” and “input name of medicine taken”.
Next, the process proceeds to ST12. In ST12, it is determined whether or not an input of a drug name and a signal indicating that the drug has been taken have been input.
　ＳＴ１２で入力が終了したと判断したときは、ＳＴ１３へ進む。ＳＴ１３では、活動量計１０が、服用した「薬剤名情報」と「体温計３」、「血圧計４」及び「血糖計５」等から薬剤服用後の「体温情報」、「血圧情報」及び「血糖値情報」を取得し、図４の「薬剤服用後バイタル情報記憶部２５」に「薬剤服用後バイタル情報」として記憶する。
　この薬剤服用後バイタル情報が、服用後生体情報の一例となっている。 If it is determined in ST12 that the input has been completed, the process proceeds to ST13. In ST13, the active mass meter 10 uses the “medical name information”, “thermometer 3”, “blood pressure meter 4”, “blood glucose meter 5”, etc. taken from the “medical temperature information”, “blood pressure information” and “ The “blood glucose level information” is acquired and stored in the “post-medical vital information storage unit 25” in FIG. 4 as “post-medical vital information”.
This post-drug vital information is an example of post-dose biometric information.
　次いで、ＳＴ１４へ進む。ＳＴ１４では、図４の「副作用発生有無判断部（プログラム）２６」が動作し、「薬剤服用前バイタル情報記憶部２４」の「薬剤服用前バイタル情報」と「薬剤服用後バイタル情報記憶部２５」の「薬剤服用後バイタル情報」を比較し、その差が図５の「副作用閾値情報記憶部３１」の「副作用閾値情報」に基づき当該薬剤の副作用と認められるか否かを判断する。
　この副作用閾値情報には、「体温」、「血圧上昇」、「血圧降下」等が副作用と認められる具体的な閾値情報を含んでいる。 Next, the process proceeds to ST14. In ST14, the “side effect occurrence determination unit (program) 26” of FIG. 4 operates, and “pre-medicine vital information” and “post-medical vital information storage unit 25” of the “pre-medicine vital information storage unit 24”. Are compared with each other, and it is determined whether or not the difference is recognized as a side effect of the drug based on the “side effect threshold information” in the “side effect threshold information storage unit 31” in FIG.
The side effect threshold information includes specific threshold information in which “body temperature”, “blood pressure increase”, “blood pressure decrease” and the like are recognized as side effects.
　次いで、ＳＴ１５へ進む。ＳＴ１５で、副作用と認められたときは、ＳＴ１６へ進む。
　ＳＴ１６では、活動量計１０が、当該薬剤を「暫定副作用薬剤」として、図４の「薬剤情報記憶部２１」の「薬剤情報２１ａ」に記憶し、活動量計側ディスプレイ１３に「警告平常時より体温が高いです。副作用を起こしたおそれがあります」と表示する。
　この「暫定副作用薬剤」情報が、薬剤副作用発生情報の一例となっている。 Next, the process proceeds to ST15. When a side effect is recognized in ST15, the process proceeds to ST16.
In ST16, the activity meter 10 stores the drug as “provisional side effect drug” in “drug information 21a” of the “drug information storage unit 21” in FIG. I have a higher body temperature. It may have caused side effects. "
This “provisional side effect drug” information is an example of drug side effect occurrence information.
　したがって、本実施の形態に係る活動量計１０は、当該活動量計１０を携帯する患者が服用した薬剤について、副作用が発生した可能性があることを自動的に判断し、その事実を記憶する。
　また、患者にとって副作用の発生を入力する必要がないので、使い易い装置となっている。 Therefore, the activity meter 10 according to the present embodiment automatically determines that a side effect may have occurred in the medicine taken by the patient carrying the activity meter 10 and stores the fact. .
In addition, since it is not necessary for the patient to input the occurrence of a side effect, the device is easy to use.
　次いで、ＳＴ１７へ進む。ＳＴ１５では、副作用発生は、あくまでも仮の暫定的な判断であるため、ＳＴ１７以下では、担当医師等による判断を仰ぐ工程となる。
　ＳＴ１７では、当該活動量計１０が「暫定副作用薬剤」と判断したデータを担当医師等が判断し、同様に「副作用」であると判断した場合に、病院サーバ６０からの「確認信号」を待つ工程となっている。
　具体的には、患者が自己の活動量計１０を携帯して、受診のため病院へ行き、担当医師に「副作用」のデータを見せる場合である。このデータを見た担当医師が、副作用と判断したときは、「確認信号」を直接又は病院サーバ６０を介して入力することになる。 Next, the process proceeds to ST17. In ST15, the occurrence of a side effect is a tentative provisional determination, and therefore, in ST17 and subsequent steps, a process for seeking a determination by a doctor in charge is requested.
In ST17, the doctor in charge or the like determines the data determined by the activity meter 10 as “provisional side effect drug” and similarly determines that it is “side effect”, and waits for the “confirmation signal” from the hospital server 60. It is a process.
Specifically, this is a case where the patient carries his / her active mass meter 10, goes to the hospital for medical examination, and shows the “side effect” data to the doctor in charge. When the doctor in charge who sees this data determines that it is a side effect, a “confirmation signal” is input directly or via the hospital server 60.
　ＳＴ１７で、「確認信号」すなわち「確定副作用薬剤」の信号入力があったときは、ＳＴ１８へ進む。ＳＴ１８では、「薬剤情報記憶部２１」の当該薬剤を「確定副作用薬剤」として記憶する。
　したがって、これにより当該薬剤が当該患者にとって副作用をもたらした「副作用薬剤」であることが確定する。
　このように、本実施の形態では、副作用の発生を一応推定して患者等に報知するが、専門家の医師等の判断を待って確定情報とするため、その確定情報は信頼性の高い情報となっている。
　また、この「確定副作用薬剤」も薬剤副作用発生情報の一例となっている。 If a “confirmation signal”, that is, a “confirmed side effect drug” signal is input in ST17, the process proceeds to ST18. In ST18, the drug in the “drug information storage unit 21” is stored as a “confirmed side effect drug”.
Therefore, this confirms that the drug is a “side effect drug” that caused side effects for the patient.
As described above, in the present embodiment, the occurrence of a side effect is temporarily estimated and notified to a patient or the like, but since the decision information is awaited by a specialist doctor or the like, the decision information is highly reliable information. It has become.
The “determined side effect drug” is also an example of drug side effect occurrence information.
　次いで、ＳＴ１９へ進む。ＳＴ１９では、「活動量計１０」は、薬剤情報２１ａの「確定副作用情報」を病院サーバ６０へ送信し、病院サーバ６０は図２の「電子カルテ情報記憶部６７」に記憶する。
　したがって、病院の「電子カルテ」においても当該患者の最新の副作用情報が自動的に反映することになり、担当医師等は薬剤の選択にあたり、常に的確な判断をすることができる。 Next, the process proceeds to ST19. In ST19, the “activity meter 10” transmits the “confirmed side effect information” of the drug information 21a to the hospital server 60, and the hospital server 60 stores it in the “electronic medical record information storage unit 67” of FIG.
Therefore, the latest side effect information of the patient is automatically reflected in the “electronic medical record” of the hospital, and the doctor in charge or the like can always make an accurate judgment when selecting the medicine.
　一方、ＳＴ１７で、「確定副作用薬剤」の信号入力がないときは、ＳＴ２０へ進む。ＳＴ２０では、当該病院サーバ６０若しくは直接に担当医師等から薬剤情報２１ａの「暫定副作用薬剤」の取消信号があったか否かを判断する。取消信号があったときは、ＳＴ２１へ進む。
　ＳＴ２１では、当該薬剤に副作用が発生していなかったとして、薬剤情報記憶部２１の当該薬剤の「暫定副作用薬剤」の情報が削除される。
　このように、本実施の形態では、担当医師等の裏付けのない情報は迅速に削除され、患者等に誤解等が生じることを未然に防ぐことができ、これにより、信頼性の高い「薬剤情報」となっている。 On the other hand, when there is no “determined side effect drug” signal input in ST17, the process proceeds to ST20. In ST20, it is determined whether or not there is a cancellation signal of “provisional side effect drug” in the drug information 21a from the hospital server 60 or a doctor in charge directly. If there is a cancel signal, the process proceeds to ST21.
In ST21, since no side effect has occurred in the drug, the information of “provisional side effect drug” of the drug in the drug information storage unit 21 is deleted.
In this way, in this embodiment, information that is not supported by the doctor in charge is quickly deleted, and it is possible to prevent misunderstandings and the like from occurring in patients and the like. "
　図９は、例えば、患者が自己の活動量計１０を携帯して、日頃受診していない医師等の診察を受ける場合、すなわち、旅行先で受診等をする場合の動作例を示す概略フローチャートである。
　先ず、医師等の診察を受ける患者等は、自己の活動量計１０を医師等に示すことになる。
　そして、医師等は、患者がどのような薬剤を服用し、また、副作用が生じるかについて知得するため、図１に示す活動量計１０を操作して、「薬剤情報２１ａ」の閲覧請求を入力する。このＳＴ３１では、このような閲覧請求が入力されたか否かが判断される。 FIG. 9 is a schematic flowchart showing an operation example when a patient carries his / her own activity meter 10 and receives a medical examination by a doctor who does not regularly visit, that is, when he / she visits a travel destination. is there.
First, a patient or the like who sees a doctor or the like shows his / her activity meter 10 to the doctor or the like.
Then, doctors and the like operate the activity meter 10 shown in FIG. 1 and input a request for viewing “drug information 21a” in order to know what drugs the patient takes and side effects. To do. In ST31, it is determined whether or not such a browsing request has been input.
　ＳＴ３１で、「薬剤情報２１ａ」の閲覧請求の入力があった場合は、ＳＴ３２へ進む。ＳＴ３２では、図５の「常薬／副作用薬剤表示処理部（プログラム）３２」が動作して、図４の「薬剤情報２１ａ」に記憶されている薬剤で「暫定副作用薬剤」又は「確定副作用薬剤」とされている「薬剤」を「副作用薬剤」として、活動量計側ディスプレイ１３に表示する。
　また、「暫定副作用薬剤」又は「確定副作用薬剤」とされていない「薬剤」は「常薬」として表示する。 In ST31, when there is an input of a request for viewing “medicine information 21a”, the process proceeds to ST32. In ST32, the “ordinary side effect drug” or “determined side effect drug” is stored in the “medicine information 21a” of FIG. Is displayed on the activity meter side display 13 as a “side effect drug”.
Further, “medicine” that is not “provisional side effect drug” or “confirmed side effect drug” is displayed as “ordinary drug”.
　ここで、活動量計１０の操作及び表示例等を図１２及び図１３を用いて説明する。図１２及び図１３は、活動量計１０の操作例及び表示例を示す概略図である。
　先ず、図１の活動量計１０の活動量計側ディスプレイ１３には、デフォルトの表示（カレンダー等）がなされているので、医師等は、活動量計側入力装置１１ｃの例えば、スイッチ１１ｃを長押しする。
　すると、図１２（ａ）に示すように、活動量計側ディスプレイ１３に「薬剤情報２１ａ」の内、上述の「常薬」に分類される薬剤名の一覧が表示される。
　この状態で、図１２（ａ）の活動量計側入力装置１１ａ、１１ｂを操作すると画面が上下にスクロールして、全ての「常薬」を容易に視認することができる。 Here, the operation and display examples of the activity meter 10 will be described with reference to FIGS. 12 and 13 are schematic diagrams illustrating an operation example and a display example of the activity meter 10.
First, since the default display (calendar or the like) is made on the activity meter side display 13 of the activity meter 10 in FIG. 1, the doctor or the like can use, for example, the switch 11c of the activity meter side input device 11c. Press.
Then, as shown in FIG. 12A, a list of drug names classified into the above-mentioned “ordinary drugs” in the “drug information 21a” is displayed on the activity meter side display 13.
In this state, when the activity meter side input devices 11a and 11b of FIG. 12A are operated, the screen scrolls up and down, and all “normal medicines” can be easily visually recognized.
　また、図１２（ａ）の状態で、スイッチ１１ｃを押下すると、図１２（ｂ）に示すように、活動量計側ディスプレイ１３に、上述の「副作用薬剤」の一覧が表示される。また、この状態で、活動量計側入力装置１１ａ、１１ｂを操作すると画面が上下にスクロールして、全ての「副作用薬剤」を容易に視認することができる。 In addition, when the switch 11c is pressed in the state of FIG. 12A, the above-mentioned “side effect drug” list is displayed on the activity meter-side display 13 as shown in FIG. 12B. Further, in this state, when the activity meter side input devices 11a and 11b are operated, the screen scrolls up and down, and all “side effect drugs” can be easily visually recognized.
　更に、図１２（ｂ）の状態で、スイッチ１１ｃを長押しすると、図１３に示すように、当該副作用薬剤、例えば、薬剤Ｅの副作用の詳細情報が表示される。図１３の例では、２０１３年２月２５日の１２時に薬剤Ｅの服用で「発熱」という副作用が発生したことが表示されている。
　また、図１３に示す状態で、活動量計側入力装置１１ａを操作すると、同一の薬剤Ｅで発生した副作用が時間毎に表示される。
　また、同様に図１３に示す状態で、活動量計側入力装置１１ｂを操作すると、異なる副作用薬剤、例えば、図１２（ｂ）の薬剤Ｆ等の副作用の詳細画面に変化させることができる。 Further, when the switch 11c is pressed and held in the state of FIG. 12B, detailed information on the side effect of the side effect drug, for example, the drug E is displayed as shown in FIG. In the example of FIG. 13, it is displayed that the side effect of “fever” has occurred in taking the medicine E at 12:00 on February 25, 2013.
Further, when the activity meter side input device 11a is operated in the state shown in FIG. 13, the side effects caused by the same medicine E are displayed every time.
Similarly, when the activity meter side input device 11b is operated in the state shown in FIG. 13, it is possible to change to a detailed screen of side effects such as different side effect drugs, for example, the drug F in FIG.
　また、図１２（ｂ）の状態で、スイッチ１１ｃを押下すると、図１２（ｃ）に示すように、「常薬」及び「副作用薬剤」を含む全体の薬剤が一覧で示されると共に、この状態で、活動量計側入力装置１１ａ、１１ｂを操作すると画面が上下にスクロールして、全ての「薬剤」を容易に視認することができる構成ともなっている。 In addition, when the switch 11c is pressed in the state of FIG. 12B, as shown in FIG. 12C, the whole medicine including “normal medicine” and “side effect medicine” is displayed in a list, and this state Thus, when the activity meter side input devices 11a and 11b are operated, the screen scrolls up and down, and all the “medicines” can be easily visually recognized.
　このように、本実施の形態では、医師等は簡単な操作で、必要な情報、例えば、副作用薬剤の名称及びその副作用の詳細等を迅速且つ的確に取得することができる。 As described above, in this embodiment, doctors and the like can obtain necessary information, for example, names of side effect drugs and details of side effects, quickly and accurately by a simple operation.
　ところで、図９のＳＴ３２の次は、ＳＴ３３へ進む。ＳＴ３３では、患者が受診している病院６の病院サーバ６０の病院側リードライト装置６１から活動量計１０に処方に係る「薬剤情報」等が送信される。
　なお、病院では処方箋を印字して手渡すだけのときは、薬局７の薬局サーバ７０の薬局側リードライト装置７１から活動量計１０に薬剤情報等が送信される。 By the way, after ST32 in FIG. 9, the process proceeds to ST33. In ST33, “medicine information” related to the prescription is transmitted to the activity meter 10 from the hospital-side read / write device 61 of the hospital server 60 of the hospital 6 where the patient is consulting.
In the hospital, when only prescription is printed and handed over, drug information or the like is transmitted from the pharmacy read / write device 71 of the pharmacy server 70 of the pharmacy 7 to the activity meter 10.
　次いで、ＳＴ３４へ進む。ＳＴ３４では、「活動量計１０」は、受信した「薬剤情報」を図４の「薬剤情報記憶部２１」に記憶する。
　次いで、ＳＴ３５へ進む。ＳＴ３５では、図５の「副作用薬剤該当判断部（プログラム）３３」が動作し、入力された「薬剤名」は、図４の「薬剤情報２１ａ」の「副作用薬剤」と一致するか否かを判断する。 Next, the process proceeds to ST34. In ST34, the “activity meter 10” stores the received “drug information” in the “drug information storage unit 21” of FIG.
Next, the process proceeds to ST35. In ST35, the “side effect drug corresponding determination unit (program) 33” in FIG. 5 operates, and it is determined whether or not the input “drug name” matches “side effect drug” in “drug information 21a” in FIG. to decide.
　ＳＴ３５で、入力された「薬剤名」が「薬剤情報２１ａ」の「副作用薬剤」と一致するときは、ＳＴ３６へ進む。
　ＳＴ３６では、活動量計側ディスプレイ１３に「警告、副作用薬剤として登録しています」と表示される。 When the input “drug name” matches “side effect drug” in “drug information 21a” in ST35, the process proceeds to ST36.
In ST36, “Registered as a warning or adverse drug” is displayed on the activity meter side display 13.
　したがって、当該患者を初めて診察する医師等が処方にかかる薬剤を決めて処方するときは、当該薬剤名等の薬剤情報を入力するだけで、その薬剤が患者の副作用薬剤であるか否かを瞬時に把握することができ、医師等にとって使い易い構成となっている。
　特に、ＳＴ３２で表示されるデータ数が多く、探している薬剤等を発見し難いときは、医師等が薬剤を探す時間を大幅に短縮することができる。 Therefore, when a doctor who examines the patient for the first time decides and prescribes a drug to be prescribed, it is possible to instantly determine whether the drug is a side effect drug of the patient simply by inputting the drug information such as the drug name. It is easy to use for doctors and the like.
In particular, when the number of data displayed in ST32 is large and it is difficult to find a drug or the like that is being searched for, it is possible to greatly reduce the time for the doctor or the like to search for the drug.
　次いで、図１０及び図１１のフローチャートを用いて、患者に処方されていた薬剤が同種薬剤である例えば、ジェネリック薬剤に変更されたときの薬効の相違等の発生の有無等を判断する工程を説明する。
　先ず、図１０のＳＴ４１で、病院６で処方時に、病院サーバ６０の病院側リードライト装置６１から活動量計１０に処方に係る「薬剤情報」等を送信する。
　薬局７から送信されるときは、薬局サーバ７０の薬局サーバ側リードライト装置７１から活動量計１０に送信される。 Next, using the flowcharts of FIG. 10 and FIG. 11, the process of determining whether or not the drug prescribed to the patient is the same type of drug, for example, the occurrence of a difference in drug efficacy when the drug is changed to a generic drug, etc. To do.
First, in ST41 of FIG. 10, at the time of prescription at the hospital 6, "medicine information" related to the prescription is transmitted from the hospital side read / write device 61 of the hospital server 60 to the activity meter 10.
When transmitted from the pharmacy 7, it is transmitted from the pharmacy server side read / write device 71 of the pharmacy server 70 to the activity meter 10.
　次いで、ＳＴ４２へ進む。ＳＴ４２では、「活動量計１０」は、受信した「薬剤情報」を図４の「薬剤情報記憶部２１」に記憶する。
　次いで、ＳＴ４３へ進む。ＳＴ４３では、入力された「薬剤名」は新規の薬剤名か、すなわち、図４の「薬剤情報２１ａ」に記憶されている薬剤名と同一か否かを判断する。 Next, the process proceeds to ST42. In ST42, the “activity meter 10” stores the received “drug information” in the “drug information storage unit 21” of FIG.
Next, the process proceeds to ST43. In ST43, it is determined whether or not the input “drug name” is a new drug name, that is, the same as the drug name stored in “drug information 21a” in FIG.
　ＳＴ４３で、同一でない、すなわち、新規であると判断されたときは、ＳＴ４４へ進む。ＳＴ４４では、新規の薬剤名は、図４の「薬剤情報２１ａ」に登録済み薬剤名と同種のジェネリック薬剤か否かを判断する。
　ＳＴ４４で、ジェネリック薬剤であると判断したときは、ＳＴ４５へ進む。ＳＴ４５では、活動量計１０が、「体温計」、「血圧計」及び「血糖計」等から薬剤服用前の「体温情報」、「血圧情報」及び「血糖値情報」を取得し、図４の「薬剤服用前バイタル情報記憶部２４」に記憶する。 If it is determined in ST43 that they are not identical, that is, they are new, the process proceeds to ST44. In ST44, it is determined whether or not the new drug name is a generic drug of the same type as the drug name registered in the “medicine information 21a” of FIG.
If it is determined in ST44 that the drug is a generic drug, the process proceeds to ST45. In ST45, the activity meter 10 acquires “body temperature information”, “blood pressure information”, and “blood glucose level information” before taking the drug from the “thermometer”, “blood pressure meter”, “blood glucose meter”, etc. Stored in the “pre-medicine vital information storage unit 24”.
　次いで、ＳＴ４６へ進む。ＳＴ４６では、「活動量計側ディスプレイ１３」に「新規薬剤を服用したか否か」及び「服用した新規薬剤名の入力」画面が表示される。
　次いで、ＳＴ４７で、新規薬剤の服用済みの信号が入力されたか否かが判断され、入力されたときは、ＳＴ４８へ進む。
　ＳＴ４８では、活動量計１０が、服用した「薬剤名情報」と「体温計」、「血圧計」及び「血糖計」等から薬剤服用後の「体温情報」、「血圧情報」及び「血糖値情報」を取得し、図４の「薬剤服用後バイタル情報記憶部２５」に記憶する。 Next, the process proceeds to ST46. In ST 46, “whether or not a new medicine has been taken” and “input of the name of a new medicine taken” screen are displayed on the “activity meter side display 13”.
Next, in ST47, it is determined whether or not a signal indicating that a new medicine has been taken has been input. If it has been input, the process proceeds to ST48.
In ST48, the active mass meter 10 uses the “medicine name information”, “thermometer”, “blood pressure meter”, “blood glucose meter”, etc. taken from the “medical temperature information”, “blood pressure information” and “blood glucose level information” after taking the drug. Is acquired and stored in the “post-medical vital information storage unit 25” in FIG.
　次いで、ＳＴ４９へ進む。ＳＴ４９では、図５の「薬効比較判断部（プログラム）３４」が動作し、「薬剤服用前バイタル情報記憶部２４」の「薬剤服用前バイタル情報」と「薬剤服用後バイタル情報記憶部２５」の「薬剤服用後バイタル情報」を比較し、その差を取得すると共に、図５の「常薬薬効情報記憶部３５」を参照して同種の薬剤の薬効と比較して薬効が劣るか否かを判断する。 Next, proceed to ST49. In ST49, the “medicine efficacy comparison / determination unit (program) 34” of FIG. 5 operates, and the “pre-medicine vital information storage unit 24” and the “pre-medicinal vital information storage unit 24” Compare the “post-drug vital information”, obtain the difference, and refer to the “regular drug efficacy information storage unit 35” in FIG. 5 to determine whether the drug efficacy is inferior to that of the same type of drug. to decide.
　この「常薬薬効情報記憶部３５」は、「薬剤情報」として記憶されている同種薬剤に対応する薬剤の過去の薬効情報が記憶されている。例えば、血圧降下剤の場合、血圧の下降程度の情報が記憶されている。
　したがって、「常薬薬効情報」が既登録の薬剤情報の薬効情報の一例となっている。 The “regular drug efficacy information storage unit 35” stores past drug efficacy information of a drug corresponding to the same type of drug stored as “drug information”. For example, in the case of an antihypertensive agent, information about a decrease in blood pressure is stored.
Therefore, “regular drug efficacy information” is an example of drug efficacy information of already registered drug information.
　次いで、ＳＴ５０へ進む。ＳＴ５０では、既存の「常薬」に比べ当該ジェネリック薬剤の薬効が劣ると判断されたときは、ＳＴ５１へ進む。ＳＴ５１では、活動量計側ディスプレイ１３に「警告　常薬を変えて薬効が低下しています」と表示される。 Next, proceed to ST50. If it is determined in ST50 that the generic drug is inferior to the existing “normal drug”, the process proceeds to ST51. In ST 51, “Warning: Drug efficacy has been reduced by changing the normal medicine” is displayed on the activity meter side display 13.
　したがって、本実施の形態では、従来服用していた薬剤をジェネリック薬剤に変更したときは、自動的にその薬効の変化を判断し、薬効の低下を患者等に報知するので、患者等は、その変化を迅速に把握することができる。 Therefore, in the present embodiment, when a drug that has been conventionally taken is changed to a generic drug, the change in the medicinal effect is automatically determined and a decrease in medicinal effect is notified to the patient. Change can be grasped quickly.
　ところで、本発明は、上述の実施の形態に限定されない。 By the way, the present invention is not limited to the above-described embodiment.
　１・・・お薬手帳管理システム、２・・・患者宅、３・・・体温計、４・・・血圧計、５・・・血糖計、６・・・病院、７・・・薬局、１０・・・活動量計、１１ａ、１１ｂ、１１ｃ・・・活動量計側入力装置、１２・・・活動量計側通信装置、１３・・・活動量計側ディスプレイ、１４・・・活動量計制御部、２０・・・第１各種情報記憶部、２１・・・薬剤情報記憶部、２１ａ・・・薬剤情報、２２・・・第１副作用発見部（プログラム）、２３・・・第２副作用発見部（プログラム）、２４・・・薬剤服用前バイタル情報記憶部、２５・・・薬剤服用後バイタル情報記憶部、２６・・・副作用発生有無判断部（プログラム）、３０・・・第２各種情報記憶部、３１・・・副作用閾値情報記憶部、３２・・・常薬／副作用薬剤表示処理部（プログラム）、３３・・・副作用薬剤該当判断部（プログラム）、３４・・・薬効比較判断部（プログラム）、３５・・・常薬薬効情報記憶部、６０・・・病院サーバ、６１・・・病院サーバ側リードライト装置、７０・・・薬局サーバ、７１・・・薬局サーバ側リードライト装置 DESCRIPTION OF SYMBOLS 1 ... Medicine notebook management system, 2 ... Patient home, 3 ... Thermometer, 4 ... Blood pressure meter, 5 ... Blood glucose meter, 6 ... Hospital, 7 ... Pharmacy, 10 ... Activity meter, 11a, 11b, 11c ... Activity meter side input device, 12 ... Activity meter side communication device, 13 ... Activity meter side display, 14 ... Activity meter Control part, 20 ... 1st various information storage part, 21 ... Drug information storage part, 21a ... Drug information, 22 ... 1st side effect detection part (program), 23 ... 2nd side effect Discovery unit (program), 24 ... pre-drug vital information storage unit, 25 ... post-drug vital information storage unit, 26 ... side effect occurrence determination unit (program), 30 ... second type Information storage unit, 31... Side effect threshold information storage unit, 32... (Program), 33 ... side effect medicine corresponding judgment part (program), 34 ... medicinal efficacy comparison judgment part (program), 35 ... regular medicine medicinal information storage part, 60 ... hospital server, 61 ... Hospital server side read / write device, 70 ... pharmacy server, 71 ... pharmacy server side read / write device

Claims (6)

  1. 　外部から各種情報を入力することができる各種情報入力部と、
    　各種情報を出力する各種情報出力部と、を備える薬剤情報管理装置であって、
    　少なくとも、処方された薬剤を特定するための情報である薬剤特定情報及びその副作用の発生情報である薬剤副作用発生情報を含む薬剤情報を既登録の前記薬剤情報として記憶すると共に、その後、前記各種情入力部から入力された前記薬剤特定情報が、前記既登録の前記薬剤情報の前記薬剤特定情報と一致するときに、当該既登録の前記薬剤情報が前記薬剤副作用発生情報と関連付けられているか否かを判断し、関連付けられているときは、当該薬剤特定情報が前記薬剤副作用発生情報を伴っていることを前記各種情報出力部に出力する構成となっていることを特徴とする薬剤情報管理装置。     Various information input units that can input various information from outside,
    A drug information management device comprising various information output units for outputting various information,
    At least drug information including drug specifying information that is information for specifying a prescribed drug and drug side effect occurrence information that is information on occurrence of side effects is stored as the already registered drug information, and thereafter, the various information Whether or not the registered drug information is associated with the drug side effect occurrence information when the drug specifying information input from the input unit matches the drug specifying information of the registered drug information The drug information management device is configured to output that the drug specifying information is accompanied with the drug side effect occurrence information to the various information output units.
  2. 　特定の薬剤の副作用判断基準情報を有し、
    　特定の薬剤の服用前における患者の生体情報である服用前生体情報を取得すると共に、当該特定の薬剤の服用後における患者の生体情報である服用後生体情報も取得し、両者の変化情報及び前記副作用判断基準情報に基づき、当該特定の薬剤に関する副作用の発生の有無を判断し、副作用が発生したと判断されたときは、前記薬剤副作用発生情報を生成する構成となっていることを特徴とする請求項１に記載の薬剤情報管理装置。     Has side effect criteria information for specific drugs,
    Obtaining pre-dose biometric information that is the patient's biometric information before taking a specific drug, and also obtaining post-dose biometric information that is the patient's biometric information after taking the specific drug, both change information and the above Based on the side effect determination criteria information, it is determined whether or not a side effect has occurred regarding the specific drug, and when it is determined that a side effect has occurred, the drug side effect occurrence information is generated. The medicine information management device according to claim 1.
  3. 　前記各種情報入力部から入力された前記薬剤特定情報に関する注意書情報に示された副作用に関する特定文言に基づいて、前記副作用判断基準情報を生成する構成となっていることを特徴とする請求項２に記載の薬剤情報管理装置。 3. The side effect determination criterion information is generated based on a specific wording regarding a side effect indicated in the precaution information regarding the drug specifying information input from the various information input units. The medicine information management device described in 1.
  4. 　入力された前記薬剤特定情報が、既登録の前記薬剤情報の前記薬剤特定情報と異なる同種薬剤であるときは、既登録の前記薬剤情報の薬効情報と比べ、前記同種薬剤の薬効が低下したと判断されたときは、薬効が低下していることを前記各種情報出力部に出力する構成となっていることを特徴とする請求項１乃至請求項３のいずれか１項に記載の薬剤情報管理装置。 When the inputted drug identification information is the same type of drug different from the drug identification information of the registered drug information, the drug efficacy of the same type of drug is reduced compared to the drug efficacy information of the registered drug information. The medicine information management according to any one of claims 1 to 3, wherein when judged, the medicine output is configured to output that the medicinal effect is lowered to the various information output units. apparatus.
  5. 　前記薬剤情報管理装置と、
    　前記薬剤情報管理装置と通信可能に配置される医療機関側薬剤管理装置と、を有する薬剤情報管理システムであって、
    　前記薬剤情報は患者の識別情報と関連付けて登録されており、この識別情報及び前記薬剤情報が、前記薬剤情報管理装置から前記医療機関側薬剤管理装置に送信され、前記医療機関側薬剤管理装置に配置される電子カルテに記録される構成となっていることを特徴とする請求項１乃至請求項４のいずれか１項に記載の薬剤情報管理装置を有する薬剤情報管理システム。     The drug information management device;
    A medicine information management system having a medical institution side medicine management apparatus arranged to be communicable with the medicine information management apparatus,
    The drug information is registered in association with patient identification information, and the identification information and the drug information are transmitted from the drug information management apparatus to the medical institution side drug management apparatus, and are sent to the medical institution side drug management apparatus. The medicine information management system having a medicine information management apparatus according to any one of claims 1 to 4, wherein the medicine information management system is recorded on an electronic medical record.
  6. 　少なくとも、処方された薬剤を特定するための情報である薬剤特定情報及びその副作用の発生情報である薬剤副作用発生情報を含む薬剤情報を既登録の前記薬剤情報として記憶すると共に、その後、外部から各種情報を入力することができる各種情入力部から入力された前記薬剤特定情報が、前記既登録の前記薬剤情報の前記薬剤特定情報と一致するときに、当該既登録の前記薬剤情報が前記薬剤副作用発生情報と関連付けられているか否かを判断し、関連付けられているときは、当該薬剤特定情報が前記薬剤副作用発生情報を伴っていることを各種情報を出力する各種情報出力部に出力する構成となっていることを特徴とする薬剤情報管理方法。 At least medicinal information including medicinal side information that is information for identifying a prescribed medicinal product and medicinal side effect occurrence information that is information on occurrence of side effects is stored as the already registered medicinal information, and thereafter, various kinds of information are externally provided. When the drug specifying information input from various information input units that can input information matches the drug specifying information of the registered drug information, the registered drug information is the drug side effect. Determining whether or not it is associated with the occurrence information, and when it is associated, a configuration for outputting that the drug specifying information is accompanied by the drug side effect occurrence information to various information output units for outputting various information; The medicine information management method characterized by becoming.
PCT/JP2013/065736 2013-06-06 2013-06-06 Drug information management device, drug information management system, and drug information management method WO2014196068A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2013/065736 WO2014196068A1 (en) 2013-06-06 2013-06-06 Drug information management device, drug information management system, and drug information management method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2013/065736 WO2014196068A1 (en) 2013-06-06 2013-06-06 Drug information management device, drug information management system, and drug information management method

Publications (1)

Publication Number Publication Date
WO2014196068A1 true WO2014196068A1 (en) 2014-12-11

Family

ID=52007740

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/065736 WO2014196068A1 (en) 2013-06-06 2013-06-06 Drug information management device, drug information management system, and drug information management method

Country Status (1)

Country Link
WO (1) WO2014196068A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019128665A (en) * 2018-01-22 2019-08-01 株式会社富士通アドバンストエンジニアリング Medication support program, device, and method
JP2021047821A (en) * 2019-09-20 2021-03-25 株式会社Ｗｉｎｄｙ Doctor medical examination support system using patient medication related information stored in dispensing pharmacy-side system and method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005100454A (en) * 2004-11-18 2005-04-14 Mitsui Sumitomo Insurance Co Ltd Health information management server and program
JP2005266853A (en) * 2004-03-16 2005-09-29 Nec Corp Pharmaceutical information management terminal, pharmaceutical information management system and pharmaceutical information management program
JP2007188149A (en) * 2006-01-11 2007-07-26 Sharp Corp Dosing information providing system, dosing information providing server, recipient terminal, program and recording medium
JP2010009536A (en) * 2008-06-30 2010-01-14 Higashi Nihon Medicom Kk Dispensing system
JP2010218439A (en) * 2009-03-18 2010-09-30 Fujitsu Ltd Prescription order issuing program, prescription order issuing apparatus and method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005266853A (en) * 2004-03-16 2005-09-29 Nec Corp Pharmaceutical information management terminal, pharmaceutical information management system and pharmaceutical information management program
JP2005100454A (en) * 2004-11-18 2005-04-14 Mitsui Sumitomo Insurance Co Ltd Health information management server and program
JP2007188149A (en) * 2006-01-11 2007-07-26 Sharp Corp Dosing information providing system, dosing information providing server, recipient terminal, program and recording medium
JP2010009536A (en) * 2008-06-30 2010-01-14 Higashi Nihon Medicom Kk Dispensing system
JP2010218439A (en) * 2009-03-18 2010-09-30 Fujitsu Ltd Prescription order issuing program, prescription order issuing apparatus and method

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019128665A (en) * 2018-01-22 2019-08-01 株式会社富士通アドバンストエンジニアリング Medication support program, device, and method
JP2021047821A (en) * 2019-09-20 2021-03-25 株式会社Ｗｉｎｄｙ Doctor medical examination support system using patient medication related information stored in dispensing pharmacy-side system and method

Similar Documents

Publication Publication Date Title
Bhardwaj et al. IoT-based smart health monitoring system for COVID-19
Nedungadi et al. Personalized health monitoring system for managing well-being in rural areas
US9945837B2 (en) Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples
KR101903407B1 (en) Health care system based on video in remote health care solution and method for providing health care service
KR100914633B1 (en) System and Method for Patient-oriented Healthcare
TW587929B (en) Medical checkup network system
US20070027367A1 (en) Mobile, personal, and non-intrusive health monitoring and analysis system
US20100169220A1 (en) Wearing health on your sleeve
US20140081087A1 (en) Mobile device system actively capturing physiological parameters
KR20060124082A (en) Apparatus for measuring health and method and system for managing health by using the apparatus
US20140310024A1 (en) Wifi cloud electronic vital-sign monitoring system
KR20140053142A (en) Method for providing health care service for providing self-aware reminder for health care motivation
KR20090065869A (en) Bio-signal detection based health management service system and its monitering method
JPWO2014119575A1 (en) Management device, management system, and management method
WO2014196068A1 (en) Drug information management device, drug information management system, and drug information management method
JP2007286947A (en) Health maintenance management system
TW201828237A (en) Method and computer program product to dynamically analyze blood sugar value to calculate the blood sugar value difference between the second blood sugar value and the first blood sugar value when the time difference is less than the first threshold value
KR20140062659A (en) U-healthcare system and method for providing u-healthcare information using health-avatar
Briggs et al. M-health review: joining up healthcare in a wireless world
US11317290B2 (en) Information processing apparatus, server, and data transmission system
Isravel et al. A novel framework for quality care in assisting chronically impaired patients with ubiquitous computing and ambient intelligence technologies
JP2006048670A (en) Medical information processing system, storage medium for medical information processing, and reader for medical information processing
Roberts Pervasive Health Management and Health Management Utilizing Pervasive Technologies: Synergy and Issues.
JP6265453B1 (en) Information discrimination system and method, information discrimination program
Ulle Challenges and Opportunities for IoT Deployment in India’s Healthcare Sector

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13886488

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13886488

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP